Product Information

VERAPAMIL ER PM 200 MG CAPSULE is a generic product labeled by Wilshire Pharmaceuticals Inc., priced at $5.6910 per EA under NDC 52536048637. Its NADAC has been published 58 times since Oct 8, 2025.

FDA first approved this application on Nov 25, 1998.

VERAPAMIL ER PM 200 MG CAPSULE

Verapamil Hydrochloride
$5.6910per EA

Strength

200 mg/1

NDC

52536048637

Classification

Generic

Dosage Form

CAPSULE, EXTENDED RELEASE

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

VERAPAMIL HYDROCHLORIDE

Approval Type

Authorized Generic (NDA)

FDA Application

NDA020943

FDA Approved

11/25/1998

On Market Since

11/26/2024

Pharmacological Classes

Calcium Channel Antagonists
Calcium Channel Blocker
Cytochrome P450 3A Inhibitors
Cytochrome P450 3A4 Inhibitors
P-Glycoprotein Inhibitors

Price Statistics

The NADAC for VERAPAMIL ER PM 200 MG CAPSULE has been published 58 times since Oct 8, 2025, and over the history we have for it it has risen 22.5%. The table below summarizes its recorded NADAC range and movement.

Current price$5.6910 per EA
All-time high$5.6910 (Nov 11, 2026)
All-time low$4.6454 (Oct 8, 2025)
52-week high$5.6910
52-week low$5.2498
Median price$5.3740
Average price$5.3452
Largest weekly change+14.0% (Nov 19, 2025)
Weeks tracked58
Tracking sinceOct 8, 2025

Price History

1W

0.0%

1M

+1.0%

3M

+2.8%

6M

+5.9%

1Y

+22.5%

3Y

N/A

5Y

N/A

All

+22.5%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 2% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

Save up to 2%

1 alternative • Same active ingredient

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of VERAPAMIL ER PM 200 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for VERAPAMIL ER PM 200 MG CAPSULE, manufactured by Wilshire Pharmaceuticals Inc., is $5.6910 per EA (NDC 52536048637), effective Nov 11, 2026.

How has the price of VERAPAMIL ER PM 200 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for VERAPAMIL ER PM 200 MG CAPSULE has risen 22.5%. It has been tracked across 58 weekly CMS publications since Oct 8, 2025.

What are the highest and lowest recorded NADAC prices for VERAPAMIL ER PM 200 MG CAPSULE?

Since Oct 8, 2025, the NADAC for VERAPAMIL ER PM 200 MG CAPSULE has ranged from a low of $4.6454 (Oct 8, 2025) to a high of $5.6910 (Nov 11, 2026), with a median of $5.3740 per EA.

Are there cheaper alternatives to VERAPAMIL ER PM 200 MG CAPSULE?

Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, VERAPAMIL ER PM 200 MG CAPSULE, is $5.5768 per EA — about 2% below VERAPAMIL ER PM 200 MG CAPSULE.

Who manufactures VERAPAMIL ER PM 200 MG CAPSULE?

VERAPAMIL ER PM 200 MG CAPSULE (NDC 52536048637) is labeled by Wilshire Pharmaceuticals Inc., and CMS classifies it as a generic product.